insights_auto
Why is PHR down 2.80%?
Dive Deeperchevron_right
PHR:NYSE
Phreesia Inc
$10.07
arrow_downward
-2.80%(-0.29) 1D
$10.07
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:07 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHR...
Open
$10.47
High
$10.47
Low
$10.06
Mkt. cap
625.05M
Avg. vol.
730.62K
Volume
528.82K
P/E ratio
59.62
52-wk high
$24.24
52-wk low
$7.77
EPS
$0.17
Beta
0.84
Shares outstanding
62.07M
No. of employees
2K
Open
$10.47
High
$10.47
Low
$10.06
Mkt. cap
625.05M
Avg. vol.
730.62K
Volume
528.82K
P/E ratio
59.62
52-wk high
$24.24
52-wk low
$7.77
EPS
$0.17
Beta
0.84
Shares outstanding
62.07M
No. of employees
2K
News stories
From web sources and news partners
Traders Union
·
56 minutes ago
S&P500 has posted gains in nearly every November-through-June period since 1942, Lia Holmgren notes
InteractiveCrypto
·
6 hours ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
Forbes
·
8 hours ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
TradingKey
·
17 hours ago
S&P 500 vs. Nasdaq 100: Which Is Better for Long-Term Investment?
Profile
Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake. Wikipedia
About Phreesia Inc
CEOChaim Indig
Employees1.79K
Founded2005
HeadquartersWilmington, Delaware, United States
SectorHealth care
Websitephreesia.com
Analyst ratings
Based on 11 analysts giving stock ratings to PHR in the past 3 months
Buy
Buy
6
Hold
5
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PHR in the last 3 months.
Highest
Current $10.07
$19.00 (+88.68%)
Average
$13.22 (+31.28%)
Lowest
$10.00 (-0.70%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ryan Daniels William Blair | Buy | Maintained | - | - | 10/02/2026 |
Parker Snure Raymond James | Hold | Downgraded | $12.00 | +19.2% | 09/08/2026 |
Joseph Vruwink Robert W. Baird | Hold | Maintained | $11.00 | +9.2% | 09/04/2026 |
Clark Wright D.A. Davidson | Buy | Maintained | $13.00 | +29.1% | 09/04/2026 |
Jailendra Singh Truist Financial | Hold | Maintained | - | - | 09/03/2026 |
Ryan Halsted RBC Capital | Buy | Maintained | $19.00 | +88.7% | 09/03/2026 |
Richard Close Canaccord Genuity | Buy | Maintained | $16.00 | +58.9% | 09/03/2026 |
Stan Berenshteyn Wells Fargo | Hold | Reiterated | $10.00 | -0.7% | 09/03/2026 |
Ryan MacDonald Needham | Buy | Reiterated | $14.00 | +39% | 09/03/2026 |
Glen Santangelo Barclays | Hold | Maintained | $10.00 | -0.7% | 09/03/2026 |
Eugene Mannheimer Freedom Capital Markets | Buy | Reiterated | $14.00 | +39% | 09/03/2026 |
Alexei Gogolev J.P. Morgan | Hold | Reiterated | $14.00 | +39% | 06/25/2026 |
Sean Dodge BMO Capital | Buy | Maintained | $14.00 | +39% | 06/22/2026 |
Jessica Tassan Piper Sandler | Hold | Downgraded | $12.00 | +19.2% | 05/28/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $20.00 | +98.6% | 05/28/2026 |
Dan Waggoner D.A. Davidson | Buy | Maintained | $14.00 | +39% | 05/28/2026 |
Daniel Grosslight Citi | Hold | Reiterated | $12.00 | +19.2% | 05/28/2026 |
Unknown Analyst KeyBanc | Buy | Reiterated | $12.00 | +19.2% | 04/13/2026 |
Scott Schoenhaus KeyBanc | Buy | Reiterated | $12.00 | +19.2% | 04/13/2026 |
Aaron Kimson Citizens JMP | Hold | Downgraded | - | - | 04/01/2026 |
Jeffrey Garro Stephens | Buy | Maintained | $20.00 | +98.6% | 03/31/2026 |
Steven Valiquette Mizuho Securities | Buy | Maintained | $19.00 | +88.7% | 03/24/2026 |
Last report
Sep 2, 2026
Fiscal period
Q2 2027
EPS / Est. (USD)
$0.28 / $0.32
-14.34%miss
arrow_downward
Revenue / Est. (USD)
129.46M / 128.99M
+0.36%beat
arrow_upward
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 120.33M | 127.07M | 130.94M | 129.46M |
Cost of goods sold | 38.03M | 40.39M | 43.33M | 43.18M |
Cost of revenue | 38.03M | 40.39M | 43.33M | 43.18M |
Research and development expenses | 29.45M | 30.92M | 28.33M | 27.57M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 39.66M | 44.37M | 42.57M | 41.10M |
Operating expense | 76.59M | 84.98M | 80.85M | 78.66M |
Total operating expenses | 114.62M | 125.37M | 124.19M | 121.85M |
Operating income | 5.71M | 1.69M | 6.75M | 7.61M |
Other non operating income | 1.01M | 1.27M | -7.00K | -2.89M |
EBT including unusual items | 5.12M | -10.32M | 4.72M | 3.24M |
EBT excluding unusual items | 7.10M | -2.57M | 4.74M | 3.24M |
Income tax expense | 854.00K | -11.62M | 1.76M | 1.32M |
Effective tax rate | 16.66% | 112.54% | 37.26% | 40.78% |
Other operating expenses | - | - | - | - |
Net income | 4.27M | 1.30M | 2.96M | 1.92M |
Net profit margin | 3.55% | 1.02% | 2.26% | 1.48% |
Earnings per share | 0.31 | 0.44 | 0.27 | 0.28 |
Interest and investment income | 700.00K | 269.00K | 297.00K | 248.00K |
Interest expense | -320.00K | -5.81M | -2.30M | -1.73M |
Net interest expenses | 380.00K | -5.54M | -2.00M | -1.48M |
Depreciation and amortization charges | 3.20M | 3.51M | 3.37M | 3.34M |
EBITDA | 13.19M | 7.67M | 12.73M | 13.58M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1